[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100573239":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":20,"locations":10,"responsibleParty":28,"collaborators":30,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":59,"overallStatus":64,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":10},{"fullName":5,"class":6},"University College Dublin","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients",null,"Patients that participated in the META trial.",{"label":13,"type":10,"description":14,"interventionNames":10},"Healthcare staff","Healthcare staff that were involved in the META trial.",[16],{"name":17,"affiliation":18,"role":19},"Walter Cullen, MD","UCD NUI: University College Dublin","PRINCIPAL_INVESTIGATOR",[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"John M Broughan, MSc","CONTACT","+353868928972","john.broughan@ucd.ie",{"name":17,"role":23,"phone":10,"phoneExt":10,"email":27},"walter.cullen@ucd.ie",{"type":29,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[31,34,37,39],{"name":32,"class":33},"University College London Institute for Global Health","UNKNOWN",{"name":35,"class":36},"National Institute for Medical Research, Tanzania","OTHER_GOV",{"name":38,"class":33},"Shree Hindu Mandal Hospital, Tanzania",{"name":40,"class":6},"Barcelona Institute for Global Health","100573239","meta-trial---a-mixed-methods-process-evaluation-100573239",false,"NCT06743698","META Trial - a Mixed Methods Process Evaluation","A Mixed Methods Process Evaluation of a Randomised Controlled Trial (META Trial) to Evaluate the Use of Metformin in HIV-Positive Persons With Pre-Diabetes","META","Inclusion Criteria:\n\n* Participants who participated in the META Trial\n* Participants who have the capacity to provide written informed consent","ALL","18 Years",{"count":52,"type":53},60,"ESTIMATED","OBSERVATIONAL","The aim of this study is to conduct a mixed methods process evaluation of the META trial. Semi-structured interviews, focus groups, and brief questionnaires will be conducted with a purposive sample of participants (patients and healthcare providers) who were involved in the trial to explore the feasibility, acceptability and perceived effectiveness of the trial intervention.",[57,58],"HIV","Pre-diabetes",[60,61,62,63,57,58],"Qualitative Research","Process evaluation","Metformin","Africa","NOT_YET_RECRUITING","2025-04-08",{"date":67,"type":68},"2025-04-11","ACTUAL",{"date":70,"type":53},"2025-06-01",{"date":72,"type":53},"2027-02",{"name":5,"class":6}]